natural glp-1 inhibitors Alternatives: Supporting Metabolic Health Glucagon-like peptide-1 receptor: mechanisms and

121 Risk mitigation strategies Effective management of gallbladder disease risk in patients undergoing GLP-1RAs therapy requires a comprehensive and individualized approach that integrates early risk stratification, patient education, lifestyle modifications, routine clinical follow-up, and targeted therapeutic interventions (Figure 3)

Within 48 weeks of stopping, participants in the placebo group had regained an average of 6.9 percentage points of body weight

GLP-1s for Osteoarthritis GLP-1 drugs may slow the progression of osteoarthritis, as research has found that people on the drugs lost more weight and had fewer knee surgeries than people not taking a GLP-1

Annu Rev Biochem 45 , 167189, (1976)